http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012328621-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279ba556d008c7c4afad8c9246e8f9fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c0ee449e8f3f1a728acb5336c420370 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41765b04e324ead7a905c218e2eccf2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbd5f053c57c23ce7973b498c8e3c9bc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0003 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13f40043fd2094bd7de420e94a1b8529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd305713882f5b985183504f048da14f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07732bbf6dde0350f96045f09924749e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e923d0a41e675d74cd4af485b0aff17 |
| publicationDate | 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2012328621-A1 |
| titleOfInvention | Immunogens, compositons and uses thereof, method for preparing same |
| abstract | The invention relates to fusion proteins comprising an amino acid sequence of a fragment H corresponding to a fragment of a calcium binding protein excreted-secreted by adult worms of Fasciola hepatica , followed by an amino acid sequence corresponding to a unrelated protein or fragment of protein, pharmaceutical compositions, vaccines and adjuvants containing the immunogen, to a process for their preparation, another process for the production of antibodies and their use. n The present invention relates to the preparation of immunogens by the addition of a peptide sequence. n Thus the present invention is useful for producing an immune response, with increases in specific antibody titers in serum against proteins or other antigens and can be applied in particular for the production of specific polyclonal antibodies, immunotherapy and immunoprophylaxis. The addition of the polypeptide to a target antigen, either through the production of recombinant proteins containing the polypeptide or by addition or fusion of this polypeptide with the target antigen, induces a significant increase in the immunogenicity of these molecules, amplifying the immune response elicited by injection of this molecule in a subject susceptible to produce antibodies. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112941058-A |
| priorityDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.